Delivery Order SPE2DB20D9331-SPE2DB25FL1Q6
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 for Stelara 90mg/ml syringes by the Defense Logistics Agency's Medical Supply Chain on July 24, 2025. The delivery order, which carries no set-aside designation, is scheduled for completion by August 11, 2025, with performance at the contractor's Park Ridge, Illinois location. This award represents a single...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency for $16,249.95 to supply Stelara 90 mg/mL syringes. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 21, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency for Stelara 90 mg/ml syringes valued at $16,249.95. The contract, issued on July 31, 2025, with an ultimate completion date of August 21, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) for the supply of Stelara 90 mg/mL syringes. The contract, awarded on July 23, 2025, carries an ultimate completion date of August 13, 2025, and represents a direct delivery order with no set-aside designation. This award falls under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 for STELARA 90 mg/ml syringes on July 24, 2025. This delivery order, which carries an ultimate completion date of August 14, 2025, was issued without a set-aside designation and is funded through the Defense Logistics Agency's Medical Supply Chain division. The award represents a single delivery order under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency's Medical Supply Chain on August 1, 2025. The delivery order is for Stelara 90 mg/ml syringes, with an ultimate completion date of August 22, 2025. This award carries no set-aside designation, allowing the vendor to compete on its merits within the broader federal procurement...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency on July 18, 2025, for the supply of Stelara 90 mg/ml syringes. This delivery order was issued without a set-aside designation and is scheduled for completion by August 8, 2025, with performance taking place in Park Ridge, Illinois. The award represents a continuation of DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $32.5K on July 22, 2025, for Stelara 90 mg/mL syringes. This firm fixed-price delivery order, which must be completed by August 12, 2025, was issued without a set-aside designation and is funded through the Defense or Civilian Medical Supply Chain agency. The contract represents a specific product fulfillment under DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award valued at approximately $195K for STELARA 90 MG/ML syringes from the Defense Logistics Agency's Medical Supply Chain on July 22, 2025. The contract represents a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's substantial...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, issued on July 21, 2025, with an ultimate completion date of August 11, 2025, carries no set-aside designation. The award represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB25FL1Q6Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency valued at $97,499.70 for Stelara 90 mg/mL syringes. The contract carries no set-aside designation and has an ultimate completion date of August 18, 2025. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.9 billion vehicle through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products to support Department of Defense healthcare facilities worldwide. Stelara is a branded biologic medication used to treat various autoimmune and inflammatory conditions. The Defense Logistics Agency utilizes such delivery orders to maintain inventory of critical pharmaceutical supplies across military medical treatment facilities and supporting healthcare operations. DMS Pharmaceutical Group has established itself as a key supplier within the federal pharmaceutical distribution network, consistently securing contracts for specialized medications including biologics, oncology treatments, vaccines, and other prescription pharmaceuticals required by the military health system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $97.5k | 7/28/25 |